Fibromuscular dysplasia is an non inflammatory non atherosclerotic obstructive arterial disease affecting mid-size arteries. It is considered as a rare vascular disease of unknown origin. Fibromuscular dysplasia may become symptomatic depending on location and severity of narrowing of the arterial lumen. for example,when a stenosis develops within a renal artery, arterial hypertension may develop. The cause of fibromuscular dysplasia is unknown. Several factors have been suggested to be associated with it: tobacco abuse or oestrogens. In order to progress into identifying possible causative mechanisms of the disease, we design a pathophysiology study destined to assess endothelial function in patients with fibromuscular dysplasia and to identify possible plasmatic biomarkers of the disease.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Masking
NONE
Enrollment
150
blood samples
endothelial function study and virtual histology study
Cic9201, Hegp, Aphp,
Paris, France
Comparison of circulating microparticles of patients vs. fibromuscular dysplasia with age and sex matched healthy volunteers and hypertensive patients
Time frame: Once within 15 days
Comparison of circulating micro RNAs (miR-143 ; miR-145) between the 3 arms
Time frame: Once within 15 days
Comparison of matrixmetalloproteases between the 3 arms
Time frame: Once within 15 days
Comparison of c-reactive protein between the 3 arms
Time frame: Once within 15 days
Comparison of PLA2 between the 3 arms
Time frame: Once within 15 days
Comparison of endothelium dependant vasodilation between the 3 arms
Time frame: Once within 15 days
Comparison of endothelium independent vasodilation between the 3 arms
Time frame: Once within 15 days
Comparison of pulse wave velocity between the 3 arms
Time frame: Once within 15 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.